{"id":"data-minimalism-exp","title":"Data Minimalism vs. Data Maximalism for Rare Disease Drug Repurposing","assumption":"More comprehensive multi-modal datasets always improve repurposing predictions","hypothesis":"Strategically minimal, high-signal datasets can outperform large, noisy multi-modal approaches for actionable rare disease drug repurposing","evaluationPlan":"Controlled comparison using 10 rare diseases, minimal vs maximal datasets, identical model architectures, evaluation on actionability scores and expert agreement","implications":"Could unlock repurposing for ultra-rare conditions with extremely limited data and fundamentally change data collection strategies","relatedWork":"Multi-modal drug repurposing (Li et al., Yang et al.), data efficiency in ML (Bengio et al.), rare disease informatics","milestones":"Month 1: Dataset curation, Month 2: Model training, Month 3: Expert evaluation","successCriteria":">15% improvement in expert actionability ratings, <50% of maximal dataset size, maintained predictive performance","priority":"high","status":"proposed","notes":"Core experiment testing fundamental data assumption","createdDate":"2025-08-12T23:28:00.000Z"}
{"id":"actionability-first-exp","title":"Actionability-First vs. Accuracy-First Model Design","assumption":"Predictive accuracy is the primary success metric for AI systems","hypothesis":"Models optimized for clinical actionability (interpretability, uncertainty quantification) produce better real-world outcomes than accuracy-optimized models","evaluationPlan":"Blinded clinician evaluation comparing accuracy-optimized vs actionability-optimized models on standardized clinical decision scenarios","implications":"Could bridge the gap between AI predictions and clinical implementation by changing fundamental evaluation metrics","relatedWork":"Interpretable ML (Ribeiro et al.), clinical decision support systems, uncertainty quantification in healthcare AI","milestones":"Month 2: Model development, Month 3: Scenario creation, Month 4: Clinician evaluation","successCriteria":">20% higher implementation likelihood, >25% improvement in clinician confidence scores","priority":"high","status":"proposed","notes":"Tests core assumption about evaluation metrics in clinical AI","createdDate":"2025-08-12T23:28:00.000Z"}
{"id":"cross-disease-transfer-exp","title":"Cross-Disease Transfer Learning Validation","assumption":"Each rare disease requires disease-specific computational approaches","hypothesis":"Shared mechanistic patterns across rare diseases can be leveraged through transfer learning to outperform disease-specific models","evaluationPlan":"Meta-learning across 50+ rare diseases, comparison against disease-specific baselines, generalization testing on novel diseases","implications":"Could enable repurposing for diseases with insufficient individual datasets and reveal universal therapeutic mechanisms","relatedWork":"Meta-learning (Finn et al.), transfer learning in biomedicine, rare disease mechanisms","milestones":"Month 4: Disease clustering, Month 5: Meta-model training, Month 6: Generalization testing","successCriteria":">30% improvement for ultra-rare diseases, successful generalization to 5+ novel diseases","priority":"medium","status":"proposed","notes":"Challenges disease-specific modeling assumption","createdDate":"2025-08-12T23:28:00.000Z"}
{"id":"parallel-validation-exp","title":"Parallel vs. Sequential Validation Strategies","assumption":"Drug validation must follow linear preclinical â†’ clinical stages","hypothesis":"Parallel validation using real-world evidence can accelerate repurposing timelines without compromising safety","evaluationPlan":"Simulation study comparing parallel vs sequential validation pathways for 20 candidate drug-disease pairs, safety outcome analysis","implications":"Could dramatically reduce time-to-treatment for rare disease patients while maintaining safety standards","relatedWork":"Real-world evidence studies, drug repurposing validation, regulatory science","milestones":"Month 6: Protocol design, Month 7: Simulation modeling, Month 8: Safety analysis","successCriteria":">40% timeline reduction, equivalent safety signal detection, maintained regulatory acceptance","priority":"medium","status":"proposed","notes":"Tests fundamental assumption about validation sequencing","createdDate":"2025-08-12T23:28:00.000Z"}
{"id":"human-ai-collaboration-exp","title":"Human-AI Collaborative Intelligence vs. Full Automation","assumption":"AI should minimize human bias and replace expert judgment","hypothesis":"Hybrid human-AI systems that amplify clinical expertise outperform fully automated approaches for complex repurposing decisions","evaluationPlan":"Comparative study with rare disease clinicians using collaborative interface vs automated predictions on complex cases","implications":"Could leverage irreplaceable rare disease expertise while scaling discovery capabilities","relatedWork":"Human-AI collaboration (Bansal et al.), clinical decision making, expert systems","milestones":"Month 6: Interface development, Month 8: Clinician studies, Month 10: Analysis","successCriteria":">25% improvement in complex case handling, >3x novel insight generation, >90% expert satisfaction","priority":"high","status":"proposed","notes":"Tests core assumption about AI vs human expertise","createdDate":"2025-08-12T23:28:00.000Z"}
{"id":"integrated-system-validation","title":"Integrated System Performance Validation","assumption":"Individual improvements cannot be combined effectively","hypothesis":"Integrated system incorporating all validated assumption flips will show synergistic benefits","evaluationPlan":"Build integrated system combining validated approaches, comprehensive comparison against state-of-the-art baselines","implications":"Demonstrates feasibility of paradigm shift in AI drug repurposing","relatedWork":"Systems integration studies, clinical AI implementation","milestones":"Month 9: System integration, Month 11: Validation studies, Month 13: Performance analysis","successCriteria":">50% improvement in overall clinical actionability, maintained prediction quality","priority":"high","status":"proposed","notes":"Validates combined benefit of all assumption flips","createdDate":"2025-08-12T23:28:00.000Z"}